Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop
Jeffery J. Auletta(Nationwide Children's Hospital), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Jennifer Holter‐Chakrabarty(University of Oklahoma Health Sciences Center), Tania Jain(Johns Hopkins University), Nandita Khera(Mayo Clinic in Florida), Alexandra Gomez-Arteaga(Cornell University), Emily Ward(National Marrow Donor Program), Anurekha G. Hall(Seattle Children's Hospital), Delilah Robb(National Marrow Donor Program), Rafeek A. Yusuf(National Marrow Donor Program), Becca Miller(National Marrow Donor Program), Eneida R. Nemecek(Oregon Health & Science University)
Cited by 10
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
|Journal of Clinical Oncology|2022|369